Australia’s Equity Venture Partners (EVP) has closed its second VC fund at A$35 million ($25 million). It will make early-stage investments in local B2B software companies.
Intudo Ventures has closed its second fund focused exclusively on Indonesian early-stage companies at $50 million. The firm raised $20 million for its debut vehicle last year.
With the acquisition of IDFC Alternatives' private equity and real estate businesses, Investcorp secured a ready-made India investment platform
Should you take a 3x return today or wait for a potentially larger exit next year? For GPs, this decision is complicated by fears of a downturn, the timing of future fundraises, and conflicting LP feedback
Allianz Investment Management, a unit of insurance giant Allianz Group, has invested over $200 million in a private debt platform managed by Edelweiss Alternative Asset Advisors, the alternative investment arm of India’s Edelweiss Group.
TPG Capital has closed its seventh pan-Asian fund at $4.6 billion after approximately two years in the market. The vehicle is already 40% committed across 12 companies.
Enterprise Angels, a New Zealand angel investor network that focuses on domestic IT, agriculture, food, horticulture, life science and biotech companies, has launched its third early-stage VC fund.
Indian venture capital firm 3one4 Capital has reached a first close on a INR3.5 billion ($50 million) fund with INR1.5 billion in commitments.
Ascendent Capital Partners is seeking $800 million for its third China mid-market fund. The GP closed its previous vehicle at $600 million in 2015.
Investors are looking to capitalize on the China distress opportunity, and recent activity in around non-performing loans suggests there will be enough deal flow to sate their appetites
Redpoint China Ventures secures $400 million for its traditional early-stage investments as well as for an expansion into growth round coverage
Invascent Capital, an Indian healthcare-focused GP, has closed its third vehicle at the hard cap of $250 million.
Bahrain-listed asset management firm Investcorp has made its first direct investment in India, acquiring the private equity and real estate investment businesses of IDFC Alternatives, the alternative asset investment arm of IDFC Group.
China consumer-focused private equity firm ClearVue Partners is seeking to raise $600 million for its third fund. It comes nearly two years after the GP closed Fund II at $362 million.
Indian asset management and equity research firm Quantum Advisors has launched a $1 billion investment fund that will take a PE-style approach to driving environmental, social, and governance (ESG) improvements in listed companies.
Japan Airlines (JAL) has provided $70 million for a venture capital fund focused on transportation technology start-ups. It will be managed by US-based TransLink Capital.
CITIC Capital has established a team to make distressed investments in China, primarily in the real estate sector, and is considering raising a fund dedicated to this strategy.
Sequoia Capital has launched Surge, an accelerator program aimed at start-ups that are either based in or targeting India and Southeast Asia.
Värde Partners has promoted Haseeb Malik, a senior managing director based in its Singapore office and head of Asia corporate and traded credit, to partner. It is one of three senior promotions announced by the firm worldwide.
Heath Zarin has taken EmergeVest out of the Asian private equity mainstream, leveraging a specialist strategy and operational expertise to create the UK’s largest private logistics business
Edelweiss Alternative Asset Advisors expands its India distress agenda with a new fund mandated for both direct debt buyouts and equity investments
With Ofo teetering on the brink of bankruptcy, bike-sharing and the broader concept of the sharing economy in China is being called into question. The survivors will be sustainable and suitably differentiated
Redpoint China Ventures has closed a $300 million fund focusing on early-stage investments and a $100 million opportunity fund looking to invest in growth-stage companies.
The Shanghai government has launched a biotech sector-focused fund targeting a hard cap of RMB50 billion ($7.35 billion) in partnership with Guotai Junan Securities, China Pacific Insurance and Shanghai Zhangjiang Group.